Colinz Laboratories Limited (COLINZ.BO)
INR 52.06
(-4.07%)
INR 52.06
(-4.07%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 5.42 Million INR | -32.38% |
| 2022 | 6.32 Million INR | 6.56% |
| 2021 | 7.56 Million INR | 44.03% |
| 2020 | 5.22 Million INR | 19.51% |
| 2019 | 3.02 Million INR | -6.69% |
| 2018 | 3.5 Million INR | 2.8% |
| 2017 | 3.58 Million INR | -8.94% |
| 2016 | 4.09 Million INR | -8.74% |
| 2015 | 4.51 Million INR | -2.76% |
| 2014 | 4.54 Million INR | 19.36% |
| 2013 | 4.73 Million INR | -24.19% |
| 2012 | 5.46 Million INR | 16.17% |
| 2011 | 5.37 Million INR | 10.58% |
| 2010 | 4.92 Million INR | 0.08% |
| 2009 | 4.85 Million INR | -13.78% |
| 2008 | 5.62 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.58 Million INR | 27.25% |
| 2024 Q2 | 2.19 Million INR | 58.59% |
| 2023 Q2 | 1.26 Million INR | -34.88% |
| 2023 Q3 | 1.89 Million INR | 49.37% |
| 2023 FY | - INR | -32.38% |
| 2023 Q1 | 1.94 Million INR | -4.24% |
| 2023 Q4 | 1.24 Million INR | -33.95% |
| 2022 Q1 | 1.87 Million INR | -0.64% |
| 2022 Q3 | 1.78 Million INR | -15.75% |
| 2022 Q4 | 2.03 Million INR | 13.66% |
| 2022 FY | - INR | 6.56% |
| 2022 Q2 | 2.12 Million INR | 13.19% |
| 2021 FY | - INR | 44.03% |
| 2021 Q1 | 1.81 Million INR | 36.01% |
| 2021 Q2 | 2.05 Million INR | 12.7% |
| 2021 Q3 | 1.83 Million INR | -10.68% |
| 2021 Q4 | 1.88 Million INR | 2.95% |
| 2020 Q2 | 1.42 Million INR | 5.02% |
| 2020 Q1 | 1.35 Million INR | 100.06% |
| 2020 Q3 | 1.11 Million INR | -21.71% |
| 2020 Q4 | 1.33 Million INR | 20.05% |
| 2020 FY | - INR | 19.51% |
| 2019 Q1 | 1.43 Million INR | 33.02% |
| 2019 FY | - INR | -6.69% |
| 2019 Q4 | 677.29 Thousand INR | -41.91% |
| 2019 Q3 | 1.16 Million INR | 4.29% |
| 2019 Q2 | 1.11 Million INR | -21.82% |
| 2018 FY | - INR | 2.8% |
| 2018 Q4 | 1.07 Million INR | 5.91% |
| 2018 Q3 | 1.01 Million INR | -27.29% |
| 2018 Q2 | 1.39 Million INR | 15.95% |
| 2018 Q1 | 1.2 Million INR | 2.29% |
| 2017 FY | - INR | -8.94% |
| 2017 Q3 | 1.37 Million INR | 2.38% |
| 2017 Q2 | 1.34 Million INR | 102.87% |
| 2017 Q4 | 1.17 Million INR | -14.4% |
| 2017 Q1 | 662 Thousand INR | -48.0% |
| 2016 Q2 | 1.74 Million INR | 33.08% |
| 2016 Q1 | 1.31 Million INR | -1.5% |
| 2016 Q4 | 1.27 Million INR | 8.71% |
| 2016 Q3 | 1.17 Million INR | -32.93% |
| 2016 FY | - INR | -8.74% |
| 2015 Q4 | 1.33 Million INR | 5.55% |
| 2015 Q2 | 1.33 Million INR | -14.0% |
| 2015 Q3 | 1.26 Million INR | -5.75% |
| 2015 FY | - INR | -2.76% |
| 2015 Q1 | 1.55 Million INR | 2.64% |
| 2014 Q2 | 1.28 Million INR | -7.03% |
| 2014 Q1 | 1.37 Million INR | 28.52% |
| 2014 Q4 | 1.51 Million INR | 8.13% |
| 2014 FY | - INR | 19.36% |
| 2014 Q3 | 1.4 Million INR | 9.44% |
| 2013 Q2 | 1.06 Million INR | -21.72% |
| 2013 Q4 | 1.07 Million INR | -12.48% |
| 2013 FY | - INR | -24.19% |
| 2013 Q1 | 1.36 Million INR | -15.64% |
| 2013 Q3 | 1.22 Million INR | 14.9% |
| 2012 Q4 | 1.61 Million INR | 26.72% |
| 2012 Q2 | 1.67 Million INR | -0.24% |
| 2012 FY | - INR | 16.17% |
| 2012 Q1 | 1.67 Million INR | 27.74% |
| 2012 Q3 | 1.27 Million INR | -23.74% |
| 2011 Q3 | 1.36 Million INR | 0.0% |
| 2011 Q4 | 1.31 Million INR | -3.95% |
| 2011 FY | - INR | 10.58% |
| 2010 FY | - INR | 0.08% |
| 2009 Q4 | 1.16 Million INR | 0.0% |
| 2009 FY | - INR | -13.78% |
| 2008 FY | - INR | 0.0% |
| 2008 Q4 | 1.6 Million INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Add-Shop E-Retail Limited | 82.61 Million INR | 93.43% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | 67.139% |
| Concord Drugs Limited | 40.52 Million INR | 86.604% |
| Denis Chem Lab Limited | 224.84 Million INR | 97.586% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | 65.812% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 99.347% |
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -749.779% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 98.563% |
| PRAVEG LIMITED | 321.43 Million INR | 98.311% |
| Smruthi Organics Limited | 120.31 Million INR | 95.488% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 97.864% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | 53.142% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 99.111% |
| Tyche Industries Limited | 128.2 Million INR | 95.766% |
| Makers Laboratories Limited | 25.81 Million INR | 78.971% |
| Beryl Drugs Limited | 26.63 Million INR | 79.624% |
| Medi-Caps Limited | 4.77 Million INR | -13.771% |
| MedPlus Health Services Limited | 3.94 Billion INR | 99.862% |
| Panchsheel Organics Limited | 189.36 Million INR | 97.134% |
| ANG Lifesciences India Limited | 90.66 Million INR | 94.013% |
| Parmax Pharma Limited | 22.93 Million INR | 76.336% |
| Parnax Lab Limited | 243.59 Million INR | 97.772% |
| Patidar Buildcon Limited | -5.52 Million INR | 198.227% |
| Bacil Pharma Limited | -569.32 Thousand INR | 1053.418% |
| Phaarmasia Limited | -1.58 Million INR | 443.11% |
| BDH Industries Limited | 124.27 Million INR | 95.632% |
| Cian Healthcare Limited | 122.56 Million INR | 95.571% |
| Mercury Laboratories Limited | 101.18 Million INR | 94.636% |
| Deccan Health Care Limited | 37.5 Million INR | 85.528% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 299.559% |
| Sastasundar Ventures Limited | -203.51 Million INR | 102.667% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | 87.885% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | 93.802% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 1436.946% |
| Sunil Healthcare Limited | 93.07 Million INR | 94.168% |
| Syschem (India) Limited | 70.4 Million INR | 92.29% |
| Trident Lifeline Limited | 102.69 Million INR | 94.714% |
| Transchem Limited | 56.61 Million INR | 90.412% |
| Trinity League India Limited | -26.25 Million INR | 120.676% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 116.764% |
| Zenith Healthcare Limited | 4.98 Million INR | -8.821% |
| Zenlabs Ethica Limited | 27.09 Million INR | 79.968% |
| Vivanza Biosciences Limited | 11.2 Million INR | 51.553% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | 54.341% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 98.597% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | 93.902% |
| Vasundhara Rasayans Limited | 84.22 Million INR | 93.555% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 103.593% |
| Roopa Industries Limited | 55.7 Million INR | 90.255% |
| PANJON LTD. | 4.08 Million INR | -32.746% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 104.403% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 128.49% |
| Anuh Pharma Limited | 878.5 Million INR | 99.382% |
| Crestchem Limited | 30.33 Million INR | 82.106% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 150.176% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | 80.039% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 98.605% |
| Trimurthi Limited | -2.47 Million INR | 319.003% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 97.494% |
| Norris Medicines Limited | -1.78 Million INR | 404.235% |
| Veerhealth Care Limited | 15.99 Million INR | 66.064% |
| Lactose (India) Limited | 201.22 Million INR | 97.302% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 105.644% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 96.818% |
| Gennex Laboratories Limited | 219.35 Million INR | 97.525% |
| Godavari Drugs Limited | 134.62 Million INR | 95.968% |
| Zenotech Laboratories Limited | 172.64 Million INR | 96.856% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 98.79% |
| Bharat Parenterals Limited | 265.74 Million INR | 97.957% |
| Coral Laboratories Limited | 227.07 Million INR | 97.61% |
| Evoq Remedies Limited | 6.18 Million INR | 12.281% |
| Kerala Ayurveda Limited | 70.78 Million INR | 92.332% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 163.315% |
| Natural Capsules Limited | 219.9 Million INR | 97.532% |
| Auro Laboratories Limited | 121.73 Million INR | 95.541% |